Erratum: Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature medicine 2007-10, Vol.13 (10), p.1264-1264
Hauptverfasser: Patil, Sandeep T, Zhang, Lu, Martenyi, Ferenc, Lowe, Stephen L, Jackson, Kimberley A, Andreev, Boris V, Avedisova, Alla S, Bardenstein, Leonid M, Gurovich, Issak Y, Morozova, Margarita A, Mosolov, Sergey N, Neznanov, Nikolai G, Reznik, Alexander M, Smulevich, Anatoly B, Tochilov, Vladimir A, Johnson, Bryan G, Monn, James A, Schoepp, Darryle D
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1264
container_issue 10
container_start_page 1264
container_title Nature medicine
container_volume 13
creator Patil, Sandeep T
Zhang, Lu
Martenyi, Ferenc
Lowe, Stephen L
Jackson, Kimberley A
Andreev, Boris V
Avedisova, Alla S
Bardenstein, Leonid M
Gurovich, Issak Y
Morozova, Margarita A
Mosolov, Sergey N
Neznanov, Nikolai G
Reznik, Alexander M
Smulevich, Anatoly B
Tochilov, Vladimir A
Johnson, Bryan G
Monn, James A
Schoepp, Darryle D
description
doi_str_mv 10.1038/nm1007-1264
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1038_nm1007_1264</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1038_nm1007_1264</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1154-d940f742f670a9b70a3be09ac4833ab4b12d4e9c550fd521294581073a653bbc3</originalsourceid><addsrcrecordid>eNotkE9Lw0AQxRdRsFZPfoG5S-xsdjd_eiulVqGgBwVvYbLZmJUkG3ZTxR795KZUGN68y3vwfozdcrznKLJF33HENOJxIs_YjCuZRDzF9_PJY5pFWa6SS3YVwiciClT5jP1uvKdx3y1h7by3H6avaAkrPdovGq3rwdXQbdt9vBDgjTbD6HwAmg568w00DN6RbmB0MHpDIwTd2IMbGm96OzUReOor19mDqeCloWAgBt3a3mpqp4il9ppd1NQGc_P_5-ztYfO6fox2z9un9WoXaT4tiapcYp3KuE5SpLycRJQGc9IyE4JKWfK4kibXSmFdqZjHuVTZNFtQokRZajFnd6de7V0I3tTF4G1H_qfgWBzxFSd8xRGf-AP_hGNI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Erratum: Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial</title><source>SpringerLink Journals</source><source>Nature</source><creator>Patil, Sandeep T ; Zhang, Lu ; Martenyi, Ferenc ; Lowe, Stephen L ; Jackson, Kimberley A ; Andreev, Boris V ; Avedisova, Alla S ; Bardenstein, Leonid M ; Gurovich, Issak Y ; Morozova, Margarita A ; Mosolov, Sergey N ; Neznanov, Nikolai G ; Reznik, Alexander M ; Smulevich, Anatoly B ; Tochilov, Vladimir A ; Johnson, Bryan G ; Monn, James A ; Schoepp, Darryle D</creator><creatorcontrib>Patil, Sandeep T ; Zhang, Lu ; Martenyi, Ferenc ; Lowe, Stephen L ; Jackson, Kimberley A ; Andreev, Boris V ; Avedisova, Alla S ; Bardenstein, Leonid M ; Gurovich, Issak Y ; Morozova, Margarita A ; Mosolov, Sergey N ; Neznanov, Nikolai G ; Reznik, Alexander M ; Smulevich, Anatoly B ; Tochilov, Vladimir A ; Johnson, Bryan G ; Monn, James A ; Schoepp, Darryle D</creatorcontrib><identifier>ISSN: 1078-8956</identifier><identifier>EISSN: 1546-170X</identifier><identifier>DOI: 10.1038/nm1007-1264</identifier><language>eng</language><ispartof>Nature medicine, 2007-10, Vol.13 (10), p.1264-1264</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1154-d940f742f670a9b70a3be09ac4833ab4b12d4e9c550fd521294581073a653bbc3</citedby><cites>FETCH-LOGICAL-c1154-d940f742f670a9b70a3be09ac4833ab4b12d4e9c550fd521294581073a653bbc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Patil, Sandeep T</creatorcontrib><creatorcontrib>Zhang, Lu</creatorcontrib><creatorcontrib>Martenyi, Ferenc</creatorcontrib><creatorcontrib>Lowe, Stephen L</creatorcontrib><creatorcontrib>Jackson, Kimberley A</creatorcontrib><creatorcontrib>Andreev, Boris V</creatorcontrib><creatorcontrib>Avedisova, Alla S</creatorcontrib><creatorcontrib>Bardenstein, Leonid M</creatorcontrib><creatorcontrib>Gurovich, Issak Y</creatorcontrib><creatorcontrib>Morozova, Margarita A</creatorcontrib><creatorcontrib>Mosolov, Sergey N</creatorcontrib><creatorcontrib>Neznanov, Nikolai G</creatorcontrib><creatorcontrib>Reznik, Alexander M</creatorcontrib><creatorcontrib>Smulevich, Anatoly B</creatorcontrib><creatorcontrib>Tochilov, Vladimir A</creatorcontrib><creatorcontrib>Johnson, Bryan G</creatorcontrib><creatorcontrib>Monn, James A</creatorcontrib><creatorcontrib>Schoepp, Darryle D</creatorcontrib><title>Erratum: Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial</title><title>Nature medicine</title><issn>1078-8956</issn><issn>1546-170X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNotkE9Lw0AQxRdRsFZPfoG5S-xsdjd_eiulVqGgBwVvYbLZmJUkG3ZTxR795KZUGN68y3vwfozdcrznKLJF33HENOJxIs_YjCuZRDzF9_PJY5pFWa6SS3YVwiciClT5jP1uvKdx3y1h7by3H6avaAkrPdovGq3rwdXQbdt9vBDgjTbD6HwAmg568w00DN6RbmB0MHpDIwTd2IMbGm96OzUReOor19mDqeCloWAgBt3a3mpqp4il9ppd1NQGc_P_5-ztYfO6fox2z9un9WoXaT4tiapcYp3KuE5SpLycRJQGc9IyE4JKWfK4kibXSmFdqZjHuVTZNFtQokRZajFnd6de7V0I3tTF4G1H_qfgWBzxFSd8xRGf-AP_hGNI</recordid><startdate>200710</startdate><enddate>200710</enddate><creator>Patil, Sandeep T</creator><creator>Zhang, Lu</creator><creator>Martenyi, Ferenc</creator><creator>Lowe, Stephen L</creator><creator>Jackson, Kimberley A</creator><creator>Andreev, Boris V</creator><creator>Avedisova, Alla S</creator><creator>Bardenstein, Leonid M</creator><creator>Gurovich, Issak Y</creator><creator>Morozova, Margarita A</creator><creator>Mosolov, Sergey N</creator><creator>Neznanov, Nikolai G</creator><creator>Reznik, Alexander M</creator><creator>Smulevich, Anatoly B</creator><creator>Tochilov, Vladimir A</creator><creator>Johnson, Bryan G</creator><creator>Monn, James A</creator><creator>Schoepp, Darryle D</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200710</creationdate><title>Erratum: Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial</title><author>Patil, Sandeep T ; Zhang, Lu ; Martenyi, Ferenc ; Lowe, Stephen L ; Jackson, Kimberley A ; Andreev, Boris V ; Avedisova, Alla S ; Bardenstein, Leonid M ; Gurovich, Issak Y ; Morozova, Margarita A ; Mosolov, Sergey N ; Neznanov, Nikolai G ; Reznik, Alexander M ; Smulevich, Anatoly B ; Tochilov, Vladimir A ; Johnson, Bryan G ; Monn, James A ; Schoepp, Darryle D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1154-d940f742f670a9b70a3be09ac4833ab4b12d4e9c550fd521294581073a653bbc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Patil, Sandeep T</creatorcontrib><creatorcontrib>Zhang, Lu</creatorcontrib><creatorcontrib>Martenyi, Ferenc</creatorcontrib><creatorcontrib>Lowe, Stephen L</creatorcontrib><creatorcontrib>Jackson, Kimberley A</creatorcontrib><creatorcontrib>Andreev, Boris V</creatorcontrib><creatorcontrib>Avedisova, Alla S</creatorcontrib><creatorcontrib>Bardenstein, Leonid M</creatorcontrib><creatorcontrib>Gurovich, Issak Y</creatorcontrib><creatorcontrib>Morozova, Margarita A</creatorcontrib><creatorcontrib>Mosolov, Sergey N</creatorcontrib><creatorcontrib>Neznanov, Nikolai G</creatorcontrib><creatorcontrib>Reznik, Alexander M</creatorcontrib><creatorcontrib>Smulevich, Anatoly B</creatorcontrib><creatorcontrib>Tochilov, Vladimir A</creatorcontrib><creatorcontrib>Johnson, Bryan G</creatorcontrib><creatorcontrib>Monn, James A</creatorcontrib><creatorcontrib>Schoepp, Darryle D</creatorcontrib><collection>CrossRef</collection><jtitle>Nature medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Patil, Sandeep T</au><au>Zhang, Lu</au><au>Martenyi, Ferenc</au><au>Lowe, Stephen L</au><au>Jackson, Kimberley A</au><au>Andreev, Boris V</au><au>Avedisova, Alla S</au><au>Bardenstein, Leonid M</au><au>Gurovich, Issak Y</au><au>Morozova, Margarita A</au><au>Mosolov, Sergey N</au><au>Neznanov, Nikolai G</au><au>Reznik, Alexander M</au><au>Smulevich, Anatoly B</au><au>Tochilov, Vladimir A</au><au>Johnson, Bryan G</au><au>Monn, James A</au><au>Schoepp, Darryle D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Erratum: Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial</atitle><jtitle>Nature medicine</jtitle><date>2007-10</date><risdate>2007</risdate><volume>13</volume><issue>10</issue><spage>1264</spage><epage>1264</epage><pages>1264-1264</pages><issn>1078-8956</issn><eissn>1546-170X</eissn><doi>10.1038/nm1007-1264</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1078-8956
ispartof Nature medicine, 2007-10, Vol.13 (10), p.1264-1264
issn 1078-8956
1546-170X
language eng
recordid cdi_crossref_primary_10_1038_nm1007_1264
source SpringerLink Journals; Nature
title Erratum: Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T06%3A37%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Erratum:%20Corrigenda:%20Activation%20of%20mGlu2/3%20receptors%20as%20a%20new%20approach%20to%20treat%20schizophrenia:%20a%20randomized%20Phase%202%20clinical%20trial&rft.jtitle=Nature%20medicine&rft.au=Patil,%20Sandeep%20T&rft.date=2007-10&rft.volume=13&rft.issue=10&rft.spage=1264&rft.epage=1264&rft.pages=1264-1264&rft.issn=1078-8956&rft.eissn=1546-170X&rft_id=info:doi/10.1038/nm1007-1264&rft_dat=%3Ccrossref%3E10_1038_nm1007_1264%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true